New Swiss biotech fund aims for E150m
Three partners, including the former manager of BB Biotech and the former head of Aventis' R&D in Europe and Japan, have set up Brilleon Capital.
Nearly there!
A verification email is on its way to you. Please check your spam or junk folder just in case.
If you do not receive this within five minutes, please try to sign in again. If the problem persists, please email: subscriptions@pei.group .-
Sign in or Register
-
Issues with signing in? Click here
Don't have an account? Register now
-
- Database
- LP search
- GP search
- Fund search
- Investment Consultant search
- Placement Agent search
- Law Firm search
- Live Fundraising Chart
- Benchmarks
- Institution Profiles Index
- Private Equity Data
- Investor Calendar 2025
- Update your database profile
- Law firm data submission
- Database key terms and methodology
- Fund performance methodology
- Quick Search
- Women of Influence in Private Markets: Call for nominations
- PEI 300: The World’s Largest Private Equity Firms
- Side Letter
- Friday Letters
- Guest Comment
- The Democratisation of Private Equity
- Spotlight: A PEI Podcast
- Magazine
- LP Perspectives 2025
- Meet the LP Series
- Top Private Equity Placement Agents
- Secondaries
- Performance
- Latest News & Analysis
- Rankings & Reports
- Events
- Bookstore
